Meeting
2020 ASCO Virtual Scientific Program
Linking insurance claims across time to characterize treatment, monitoring, and end-of-life care in metastatic breast cancer.
Authors
Jennifer Lee Caswell-Jin
Stanford University, Stanford, CA
Jennifer Lee Caswell-Jin , Alison Callahan , Natasha Purington , Summer S. Han , Haruka Itakura , George W. Sledge Jr., Nigam Shah , Allison W. Kurian
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research and Quality Improvement
Track
Quality Care/Health Services Research
Sub Track
Real-World Data/Outcomes
Citation
J Clin Oncol 38: 2020 (suppl; abstr 7063)
DOI
10.1200/JCO.2020.38.15_suppl.7063
Abstract #
7063
Poster Bd #
335
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Distribution and outcomes of HER2-low and HER2-zero metastatic breast cancer in Black and younger women.
First Author: Paola Zagami
First Author: Cristina I. Truica
Poster
2020 ASCO Virtual Scientific Program
The efficacy of first-line chemotherapy in endocrine-resistant hormone receptor-positive (HR+), human epidermal growth factor receptor 2- negative (HER2-) metastatic breast cancer (MBC).
First Author: Sudpreeda Chainitikun
Poster
2020 ASCO Virtual Scientific Program
Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2+/HR+ metastatic breast cancer.
First Author: Matthew Loft